Skip to main content

Garren Hideki's Form 4 filing

Prothena Corp Public Ltd Co (PRTA) · filed Jun 16, 2023

Accession no.
0001140361-23-030333
Filed
Jun 16, 2023
Trade date
Jun 16, 2023
Filing delay
Same day
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $542.5K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Garren HidekiCIK 0001854126Officer (Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 16, 2023Ordinary Shares, par value $0.01 per shareMOption exerciseAcquired+7,331$24.90+$182,541.97,331Direct
Jun 16, 2023Ordinary Shares, par value $0.01 per shareSSaleDisposed−7,331$74.00−$542,4940Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 16, 2023Ordinary SharesMOption exerciseDisposed−7,331$0.00$0198,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)